Price | Targeted cancer therapy with tyrosine kinase inhibitors
Price Tyrosine kinase inhibitors are active ingredients from the group of genetically engineered monoclonal antibodies. This newer, targeted treatment of cancer is still very expensive. As a rule, it is a long-term or even life-long therapy to suppress a relapse. Glivec (contains the active ingredient Imatinib) in the therapy of chronic myeloid leukemia costs over … Price | Targeted cancer therapy with tyrosine kinase inhibitors